Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 8/20 | 0.60 |
| ▸ | NPY4R | P50391 | 8/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.60 |
| ▸ | NPY1R | P25929 | 6/20 | 0.60 |
| ▸ | KDM1A | O60341 | 2/20 | 0.57 |
| ▸ | TFPI | P10646 | 4/20 | 0.56 |
| ▸ | EP300 | Q09472 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | CALCR | P30988 | 2/20 | 0.54 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.54 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.54 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28731660 | 0.98 | NPY2R (0.60) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL29263405 | 0.93 | NPY2R (0.62) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL21462828 | 0.91 | NPY2R (0.62) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL21462831 | 0.91 | NPY2R (0.62) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL30436596 | 0.87 | MAPK8 (0.65) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL29903341 | 0.87 | NPY2R (0.66) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL29679864 | 0.87 | MAPK8 (0.62) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL30607334 | 0.87 | NPY2R (0.68) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL30432199 | 0.86 | NPY2R (0.67) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL30338084 | 0.85 | NPY2R (0.62) | NPY2RNPY4RNPY5RNPY1RKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114502595-A | Antibodies against poliovirus receptor (PVR) and uses thereof | 奈克汀治疗有限公司 | 2022-05-13 | — | — | CN | disclosed |